Kurt Selle, Ph.D.
Dr. Kurt Selle joined BTEC in 2020 as a senior scientist supporting the Accelerated Innovation in Manufacturing Biologics (AIM-Bio) program. Previously, he was a lead scientist and manager at Locus Biosciences and was responsible for establishing a synthetic biology platform for early drug development, intellectual property generation, and clinical readiness of a first-in-class recombinant phage biologic. His research experience bridges the disciplines of bacteriology, phage and CRISPR biology, molecular genetics, biotechnology, and high-throughput data technologies, applying those competencies across probiotic, pathogenic, and fermentative bacteria towards understanding fermentation microbiology and improving human-microbe interactions.
Dr. Selle received a Ph.D. in functional genomics from NC State. His graduate research focused on CRISPR-Cas genome editing in fermentative and beneficial bacteria and using high-throughput sequencing to characterize large chromosomal deletion mutants and their expression profiles.